X
26Aug

Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla

Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By: Robins Kaplan LLP
Source Url: https://www.jdsupra.com/legalnews/financial-daily-dose-8-26-2019-top-43922/

Related

How COVID-19 is impacting ADG M&A

Special series focused on the impact of the COVID-19 pandemic on the Aerospace, Defense, and Governm...

Read More >

Federal Court Preliminary Enjoins Enforcement of New California Arbitration Law AB 51

On Friday, January 31, 2020, Chief District Judge Kimberly J. Mueller of the federal District Court ...

Read More >

ASBCA Confirms that the Government’s Failure to Identify a Defect During Construction is a Constructive Waiver of the Specifications

Many federal construction contractors have been there: it’s near the end of the project and the gov...

Read More >

Russia Adopts New Investment Law

President Vladimir Putin signed a package of laws (informally referred to as the Investment Code) on...

Read More >

Healthcare & Life Sciences Private Equity Deal Tracker: Frazier Healthcare Partners Acquires Accuity Delivery Systems

Frazier Healthcare Partners has announced it has acquired Accuity Delivery Systems....By: McGuireWoo...

Read More >

Timing (and purpose) is everything: The importance of prompt disclosure to admissibility of video surveillance evidence

In Nemchin v. Green, the Court of Appeal for Ontario clarified a number of important aspects of the ...

Read More >